FOXO Technologies Email Format
Biotechnology ResearchMinnesota, United States2-10 Employees
FOXO Technologies is a small biotechnology research company based in Minneapolis, Minnesota. It aims to transform longevity insurance underwriting by combining a forward-looking underwriting protocol with a consumer engagement platform that draws on epigenetic information. The company uses data-driven methods to identify epigenetic biomarkers that reflect current health and aging states, supporting more informed risk assessment and user engagement. Its target customers include longevity insurers seeking better underwriting insights and individuals seeking information about their health and aging. In 2025, FOXO announced an acquisition agreement to acquire Vector Biosource Inc.